Stock ScreenerStock IdeasHigh Risk, High Reward
High Risk, High Reward Stocks
Speculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!

Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
Ticker
Company
Market Cap
Dividend Yield
Payout Ratio
Last Dividend
Annual Dividend
Dividend Percentile
Dividend Dropped Count (L10Y)
Ex-dividend Date
Div. Payment Date
KALA
KALA BIO INC
$4.56MN/A0.00%N/AN/AN/AN/A
FBLG
FIBROBIOLOGICS INC
$18.94MN/A0.00%N/AN/AN/AN/A
IMA
IMAGENEBIO INC
$91.30MN/A0.00%N/AN/AN/AN/A
CANF
CAN-FITE BIOPHARMA LTD
$4.40MN/AN/AN/AN/AN/AN/A
ATYR
ATYR PHARMA INC
$73.78MN/A0.00%N/AN/AN/AN/A
BTAI
BIOXCEL THERAPEUTICS INC
$35.65MN/A0.00%N/AN/AN/AN/A
NRXP
NRX PHARMACEUTICALS INC
$69.96MN/A0.00%N/AN/AN/AN/A
SGMO
SANGAMO THERAPEUTICS INC
$149.74MN/A0.00%N/AN/AN/AN/A
PSTV
PLUS THERAPEUTICS INC
$70.09MN/A0.00%N/AN/AN/AN/A
TVRD
TVARDI THERAPEUTICS INC
$37.81MN/A0.00%N/AN/AN/AN/A
GRI
GRI BIO INC
$5.52MN/A0.00%N/AN/AN/AN/A
ACET
ADICET BIO INC
$101.46MN/A0.00%N/AN/AN/AN/A
KRRO
KORRO BIO INC
$57.16MN/A0.00%N/AN/AN/AN/A
SKYE
SKYE BIOSCIENCE INC
$41.67MN/A0.00%N/AN/AN/AN/A
CING
CINGULATE INC
$23.58MN/A0.00%N/AN/AN/AN/A
LSTA
LISATA THERAPEUTICS INC
$18.70MN/A0.00%N/AN/AN/AN/A
PHIO
PHIO PHARMACEUTICALS CORP
$13.99MN/A0.00%N/AN/AN/AN/A
MTVA
METAVIA INC
$16.93MN/A0.00%N/AN/AN/AN/A
VNRX
VOLITIONRX LTD
$40.65MN/A0.00%N/AN/AN/AN/A
CYBN
CYBIN INC
$136.59MN/A0.00%N/AN/AN/AN/A
ENLV
ENLIVEX THERAPEUTICS LTD
$24.07MN/A0.00%N/AN/AN/AN/A
RNXT
RENOVORX INC
$27.49MN/A0.00%N/AN/AN/AN/A
ZYXI
ZYNEX INC
$17.27MN/A0.00%$0.1000N/AN/A0
MYO
MYOMO INC
$31.36MN/A0.00%N/AN/AN/AN/A
BOLT
BOLT BIOTHERAPEUTICS INC
$8.77MN/A0.00%N/AN/AN/AN/A
MBRX
MOLECULIN BIOTECH INC
$22.10MN/A0.00%N/AN/AN/AN/A
AVXL
ANAVEX LIFE SCIENCES CORP
$313.08MN/A0.00%N/AN/AN/AN/A
SLN
SILENCE THERAPEUTICS PLC
$322.29MN/AN/AN/AN/AN/AN/A
TIL
INSTIL BIO INC
$97.80MN/A0.00%N/AN/AN/AN/A
CTSO
CYTOSORBENTS CORP
$41.45MN/A0.00%N/AN/AN/AN/A
NAKA
KINDLY MD INC
$4.67MN/A0.00%N/AN/AN/AN/A
SNSE
SENSEI BIOTHERAPEUTICS INC
$10.10MN/A0.00%N/AN/AN/AN/A
IMUX
IMMUNIC INC
$93.70MN/A0.00%N/AN/AN/AN/A
IFRX
INFLARX NV
$91.46MN/A0.00%N/AN/AN/AN/A
ATOS
ATOSSA THERAPEUTICS INC
$103.34MN/A0.00%N/AN/AN/AN/A
HUMA
HUMACYTE INC
$230.34MN/A0.00%N/AN/AN/AN/A
JSPR
JASPER THERAPEUTICS INC
$47.01MN/A0.00%N/AN/AN/AN/A
RVPH
REVIVA PHARMACEUTICALS HOLDINGS INC
$57.76MN/A0.00%N/AN/AN/AN/A
CABA
CABALETTA BIO INC
$222.37MN/A0.00%N/AN/AN/AN/A
BMEA
BIOMEA FUSION INC
$90.50MN/A0.00%N/AN/AN/AN/A
AMTX
AEMETIS INC
$125.89MN/A0.00%N/AN/AN/AN/A
BNGO
BIONANO GENOMICS INC
$15.47MN/A0.00%N/AN/AN/AN/A
NKTX
NKARTA INC
$132.83MN/A0.00%N/AN/AN/AN/A
AKTX
AKARI THERAPEUTICS PLC
$37.81MN/AN/AN/AN/AN/AN/A
CATX
PERSPECTIVE THERAPEUTICS INC
$154.62MN/A0.00%N/AN/AN/AN/A
SNTI
SENTI BIOSCIENCES INC
$42.33MN/A0.00%N/AN/AN/AN/A
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.